𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacology of mitoxantrone in cancer patients

✍ Scribed by Niramol Savaraj; Katherine Lu; Valdivieso Manuel; Ti Li Loo

Publisher
Springer
Year
1982
Tongue
English
Weight
389 KB
Volume
8
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II studies of mitoxantrone in pati
Phase II studies of mitoxantrone in patients with primary liver cancer
✍ Geoffrey Falkson; Barend Johannes Coetzer πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 147 KB

Forty-nine patients with histologically conlirmed primary liver cancer have been entered on phase II trials of mitoxantrone (NovantroneC"~; dihydroxyanthracenedione), at a dose of 14 mg/m 2 every 3 weeks. Among the patients evaluable for toxicity, leukopenia and thrombocytopenia were the most import

Human central nervous system and plasma
Human central nervous system and plasma pharmacology of mitoxantrone
✍ R. M. Green; D. J. Stewart; H. Hugenholtz; M. T. Richard; M. Thibault; V. Montpe πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 565 KB

Mitoxantrone 5 -6 mg/m 2 was administered IV to 10 consenting patients prior to surgical resection of an intracerebral tumor. Plasma pharmacokinetic parameters were calculated and concentration of mitoxantrone in intracerebral tumors was determined. Concentrations of mitoxantrone were also determine